Table 3.
Laboratory Results of 26 Patients with COVID-19 in Liaocheng Infectious Disease Hospital (Jan 31–Feb 12, 2020)
| n=26 | |
|---|---|
| Blood Routine | |
| Leucocytes (× 10⁹/L; normal range 4.0–10.0) | 5.3 (4.3–6.6) |
| Increased | 1 (3.9%) |
| Decreased | 5 (19.2%) |
| Neutrophils (× 10⁹/L; normal range 2.0–7.7) | 3.7 (2.8–4.9) |
| Increased | 2 (7.7%) |
| Decreased | 3 (11.5%) |
| Lymphocytes (× 10⁹/L; normal range 0.8–4.0) | 0.8 (0.6–1.4) |
| Decreased | 11 (42.3%) |
| Monocyte (× 10⁹/L; normal range 0.12–0.8) | 0.4 (0.3–0.6) |
| Increased | 1 (3.9%) |
| Platelets (× 10⁹/L; normal range 100.0–300.0) | 191.0 (156.8–250.3) |
| Increased | 4 (15.4%) |
| Haemoglobin (g/L; normal range 110.0–160.0) | 140.0 (120.8–153.3) |
| Increased | 2 (7.7%) |
| Decreased | 5 (19.2%) |
| Coagulation Function | |
| Prothrombin time (s; normal range 11.0–14.0) | 12.6 (12.2–13.1) |
| Increased | 2 (7.7%) |
| Decreased | 1 (3.9%) |
| Activated partial thromboplastin time (s; normal range 22.0–38.0) | 28.7 (25.5–33.5) |
| Increased | 2 (7.7%) |
| Decreased | 2 (7.7%) |
| D-dimer (µg/mL; normal range 0.0–1.0) | 0.3 (0.2–0.4) |
| Increased | 1 (3.9%) |
| Blood Biochemistry | |
| Albumin (g/L; normal range 35.0–55.0) | 38.7 (35.7–40.6) |
| Decreased | 5 (19.2%) |
| Alanine aminotransferase (U/L; normal range 0.0–40.0) | 18.0 (14.0–23.0) |
| Aspartate aminotransferase (U/L; normal range 0.0–40.0) | 19.5 (16.8–21.3) |
| Total bilirubin (μmol/L; normal range 0.0–21.0) | 12.2 (10.3–16.3) |
| Increased | 1 (3.9%) |
| Blood urea nitrogen (mmol/L; normal range 1.69–8.34) | 3.2 (2.7–3.5) |
| Decreased | 1 (3.9%) |
| Serum creatinine (μmol/L; normal range 44.0–97.0) | 55.6 (42.0–61.6) |
| Decreased | 7 (26.9%) |
| Creatine kinase (U/L; normal range 24.0–194.0) | 67.5 (50.8–88.8) |
| Lactate dehydrogenase (U/L; normal range 109.0–245.0) | 216.5 (180.5–240.3) |
| Increased | 6 (23.1%) |
| Creatine kinase-MB (U/L; normal range 0.0–2 5.0) | 13.0 (11.0–17.0) |
| Increased | 2 (7.7%) |
| Glucose (mmol/L; normal range 3.90–6.44) | 5.1 (4.9–5.6) |
| Increased | 4 (15.4%) |
| Infection-Related Biomarkers | |
| Procalcitonin (ng/mL; normal range 0.0–0.05) | 0.2 (0.1–0.3) |
| Increased | 24 (92.3%) |
| Hypersensitive C-reactive protein (mg/L; normal range 0.5–10.0) | 11.5 (1.4–28.7) |
| Increased | 14 (53.9%) |
| Serum amyloid A (mg/L; normal range 0.0–10.0) | 12.7 (5.0–66.9) |
| Increased | 16 (61.5%) |
Note: Variables presented as median (interquartile range) or number of patients, n (%).